NCT06264024 Simultaneous pHototherapeutic Keratectomy and corneAl Collagen cRosslinking in Eyes With Keratoconus: a Randomized Trial (SHARK)
| NCT ID | NCT06264024 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Oslo University Hospital |
| Condition | Keratoconus |
| Study Type | INTERVENTIONAL |
| Enrollment | 81 participants |
| Start Date | 2024-02-12 |
| Primary Completion | 2025-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 81 participants in total. It began in 2024-02-12 with a primary completion date of 2025-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to compare CXL with combined treatment with CXL and t-PTK. The main questions it aims to answer are whether combined treatment can give better visual acuity and if the treatments are equally safe.
Eligibility Criteria
Inclusion Criteria: * Patients must be 18 years or older at the time of signing the informed consent form. There is no upper age limit. * Progressive keratoconus with indication for CXL * Corneal thickness ≥ 420 μm Exclusion Criteria: * Other eye disease causing visual impairment
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06264024 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Keratoconus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06264024 currently recruiting?
Yes, NCT06264024 is actively recruiting participants. Contact the research team at olakri@ous-hf.no for enrollment information.
Where is the NCT06264024 trial being conducted?
This trial is being conducted at Oslo, Norway.
Who is sponsoring the NCT06264024 clinical trial?
NCT06264024 is sponsored by Oslo University Hospital. The trial plans to enroll 81 participants.